Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
Where is a list of all biosimilar drugs that have been approved in the U.S.?
The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here.
What biosimilar drugs have been approved in the USA?
The following biosimilar drugs have been approved in the U.S.:
| Biosimilar Drug Name | Approval Date | Reference Product |
| Zarxio (Filgrastim) | March 2015 | Neupogen |
| Inflectra (Infliximab) | April 2016 | Remicade |
| Erelzi (Etanercept) | April 2016 | Enbrel |
| Amjevita (Adalimumab) | September 2016 | Humira |
| Renflexis (Infliximab) | May 2017 | Remicade |
| Cyltezo (Adalimumab) | August 2017 | Humira |
| Mvasi (Bevacizumab) | September 2017 | Avastin |
| Ogivri (trastuzumab) | December 2017 | Herceptin |
| Ixifi (infliximab) | December 2017 | Remicade |
Where is a list of all biologics that have been approved in the U.S.?
The FDA maintains a list of approved biologics cataloged by year and archived back to 2014 here.